Project cooperationUpdated on 18 February 2026
Working AI platform for medical device regulatory gap analysis — seeking IND-03 consortium
CEO at Klaris
London, United Kingdom
About
Most AI-for-regulatory proposals promise a platform that will be built during the project. We already have one in production.
Klaris AI is a London-based MedTech startup focused on one problem: medical device companies spend months and hundreds of thousands of euros on regulatory documentation that still comes back with gaps. Our platform uses AI trained on device-specific regulatory frameworks to automate gap analysis in technical documentation.
For a consortium targeting IND-03, we offer something specific: a working AI system that can serve as the testbed for validating improved regulatory methodologies and evidence frameworks across the device lifecycle. This means the consortium can demonstrate real-world applicability from day one rather than spending the first 18 months on platform development.
Topic
- DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
Type
- Partner seeks Consortium/Coordinator
Organisation
Similar opportunities
Project cooperation
- DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
Delphine Ribes Lemay
Engineer/ Head of Group at EPFL+ECAL LAB
Lausanne, Switzerland
Project cooperation
- Consortium/Coordinator seeks Partners
- Partner seeks Consortium/Coordinator
- DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-03: Building public trust and outreach in the life sciences
- DESTINATION 4: HORIZON-HLTH-2026-01-CARE-03: Identifying and addressing low-value care in health and care systems
- DESTINATION 2: HORIZON-HLTH-2026-01-ENVHLTH-04: Towards climate resilient, prepared and carbon neutral populations and healthcare systems
- DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
- DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-02: Behavioural interventions as primary prevention for Non-Communicable Diseases (NCDs) among young people
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
- DESTINATION 4: HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens' access to healthcare through integrated or personalised approaches
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-02: Innovative interventions to prevent the harmful effects of using digital technologies on the mental health of children and young adults
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
Fatih Eren
R&D Incentive Management Specialist at İnnova IT Solutions
Ankara, Türkiye
Project cooperation
Advancing Single-Molecule De-Novo Protein Sequencing
- Consortium/Coordinator seeks Partners
- Partner seeks Consortium/Coordinator
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
Til Schlotter
ETH Researcher, Co-founder & CEO at UNOMR AG
Zurich, Switzerland